- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06525753
Weaning is Winning? (WeWin Study)
October 15, 2024 updated by: Jessie Hulst, The Hospital for Sick Children
Weaning is Winning? (WeWin Study): Are Parenteral Nutrition (PN) Graduates Growing Up Healthy?
We propose a multicenter prospective study on pediatric patients with intestinal failure (IF) who weaned off parenteral nutrition (PN).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Children with IF depend on PN.
This is associated with frequent and various complications such as metabolic bone disease, micronutrient deficiencies and abnormal body composition.
Due to advancements in care, many patients with IF are able to wean off PN; they are so called PN graduates.
It is currently not well known how often complications do occur after weaning off PN, and which patients are at highest risk of developing these complications.
Study Type
Observational
Enrollment (Estimated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Recruiting
- The Hospital for Sick Children
-
Contact:
- Jessie Hulst, MD, PhD
- Email: jessie.hulst@sickkids.ca
-
Contact:
- Zujaja-Tul-Noor Zujaja-Tul-Noor, MSc
- Email: zujaja.tul-noor@sickkids.ca
-
Contact:
- Jessie Hulst
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Parenteral Nutrition graduates, i.e.: patients weaned off Parenteral Nutrition at time of inclusion for at least 1 year, with a history of intestinal failure, defined as dependence on supplemental PN support for a minimum of 60 days within a 74 consecutive day interval and followed by the Group for Improvement of Intestinal Function and Treatment (GIFT) team (SickKids) or IF team (Erasmus MC) as an outpatient.
Description
Inclusion Criteria:
- Parenteral Nutrition graduates for at least 1 year, with a history of intestinal failure.
- Age <18 years at time of inclusion.
Exclusion criteria:
- No consent provided.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
SickKids
Patients recruited from the Hospital for Sick Children (SickKids), Toronto, Canada
|
pediatric intestinal failure patients who have been weaned off parenteral nutrition
|
|
Erasmus
Patients recruited from the Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
|
pediatric intestinal failure patients who have been weaned off parenteral nutrition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: From 1 year after weaning off PN to 18 years of age
|
Assess the frequency of nutritional complications including poor growth, micronutrient deficiencies, poor bone health, abnormal body composition, and delayed pubertal development in PN graduates.
|
From 1 year after weaning off PN to 18 years of age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2024
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 1, 2034
Study Registration Dates
First Submitted
July 24, 2024
First Submitted That Met QC Criteria
July 24, 2024
First Posted (Actual)
July 29, 2024
Study Record Updates
Last Update Posted (Actual)
October 17, 2024
Last Update Submitted That Met QC Criteria
October 15, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000080824
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
All participants will be assigned a unique study ID (identification) known only to the study investigators/coordinators.
The unique study IDs will only be identifiable through an encrypted master-linking log stored on a secure hospital server and shared folder that is only accessible to designated study staff on each site.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Failure
-
University Hospital, BordeauxCompletedChronic Intestinal FailureFrance
-
Geert WantenBaxter Healthcare CorporationCompletedIntestinal FailureNetherlands
-
University Hospital, GhentCompleted
-
NorthSea Therapeutics B.V.RecruitingIntestinal Failure Associated Liver DiseaseUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedIntestinal FailureMexico
-
Seattle Children's HospitalNational Center for Research Resources (NCRR); Thrasher Research FundCompletedIntestinal Failure | Rotavirus VaccinesUnited States
-
University of PittsburghCompletedAllograft Rejection | Irreversible Intestinal FailureUnited States
-
Protara TherapeuticsCompletedIntestinal Failure-associated Liver DiseaseUnited States, Denmark, United Kingdom, Italy
-
SterileCare Inc.Dicentra Inc.; Meditrial SrLRecruitingPediatric Intestinal FailureUnited States
-
Children's Hospital Medical Center, CincinnatiEnrolling by invitation
Clinical Trials on Weaning off Parenteral Nutrition
-
Hospital Pediátrico de SinaloaRecruitingCholestasis in NewbornMexico
-
RESnTEC, Institute of ResearchCompletedRespiratory Distress Syndrome, NewbornPakistan
-
Instituto do Cancer do Estado de São PauloUnknownCancer | Abdominal Surgery | Parenteral NutritionBrazil
-
Göteborg UniversityCompleted
-
Karaganda Medical UniversityCompletedPostoperative | Nutritional Support | Hepato-Biliary NeoplasmKazakhstan
-
University of ManchesterShire International GmbHCompleted
-
University Hospital, LilleMinistry of Health, FranceTerminatedGastrointestinal Fistula | Enteral Nutritional SupportFrance
-
London North West Healthcare NHS TrustSt Mark's Hospital FoundationUnknownEnterocutaneous FistulaeUnited Kingdom
-
Lawson Health Research InstituteUnknownMalignant Hematologic NeoplasmCanada
-
Dong ZhangRecruitingCritical Illness | Organ Dysfunction | Enteral Nutrition Intolerance | Inadequate Nutritional IntakeChina